Bobby Williams v. Robert B. Greifinger, Deputy Commissioner and Chief Medical Officer of the New York State Department of Correctional Services

97 F.3d 699, 1996 U.S. App. LEXIS 26793
CourtCourt of Appeals for the Second Circuit
DecidedOctober 15, 1996
Docket1966, Docket 96-2163
StatusPublished
Cited by90 cases

This text of 97 F.3d 699 (Bobby Williams v. Robert B. Greifinger, Deputy Commissioner and Chief Medical Officer of the New York State Department of Correctional Services) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bobby Williams v. Robert B. Greifinger, Deputy Commissioner and Chief Medical Officer of the New York State Department of Correctional Services, 97 F.3d 699, 1996 U.S. App. LEXIS 26793 (2d Cir. 1996).

Opinion

LOUIS H. POLLAK, Senior District Judge:

Plaintiff Bobby Williams, an inmate at Sing Sing Correctional Facility, seeks to challenge a policy under which he was held in a status called “medical keeplock” for 589 days, without any opportunity for out-of-cell exercise, as a result of his refusal to take a tuberculosis test. Claiming that this policy’s bar on out-of-cell exercise violated the Eighth Amendment, he has brought suit, under 42 U.S.C. § 1983, against Robert Grei-finger, who was Deputy Commissioner and Chief Medical Officer of the New York State Department of Correctional Services (“DOCS”) during Williams’s confinement in medical keeplock. 1 Greifinger was instrumental in designing and authorizing the medical keeplock policy. In response to cross-motions for summary judgment, the district court ruled that the medical keeplock policy did indeed violate the Eighth Amendment, but that Greifinger is immune from suit under the doctrine of qualified immunity. Williams now appeals from the latter ruling.

I. BACKGROUND

Except where noted, the following recitation of facts is not disputed by the parties.

There has been a broad increase in tuberculosis (“TB”) infection nationwide. Prisons have been particularly affected by this trend; prison inmates tend to be in poorer health than the general population, and so are more susceptible to contagion. The nature of prison life also facilitates disease transmission. As a result, in the three years preceding the end of 1993, there were 27 deaths from TB in the prisons of New York State, including that of one correctional officer.

In late 1991, DOCS responded to the rise in TB infection by instituting a tuberculosis *701 control program. A few important facts about TB itself will aid in explaining the nature of this program. TB infections take two forms, “latent” and “active” cases. Persons with latent TB are infected with the bacterium that causes TB, but have no obvious symptoms, and are not ordinarily contagious. Persons with active TB, by contrast, have symptoms (including coughing, sweating, and fever) and are contagious. A prisoner who is known to have latent TB can be given a course of treatment, termed “INH therapy,” which will greatly reduce the risk that he or she will develop active TB. (Generally, however, a latent TB infection cannot be eliminated altogether.)

Active TB can be detected through sputum samples and chest x-rays. Latent TB is detected through the purified protein derivative (“PPD”) test, which involves injecting a compound under the skin; in individuals with latent TB, the injection will cause a skin reaction. The test causes side effects in some, including “redness, soreness, or an open lesion”; these side effects do not, however, pose a serious health risk. Joint App. at 32.

Under DOCS’s program, inmates and staff at facilities under DOCS’s authority are tested for latent TB on arrival, and retested annually thereafter. Individuals who are found to have latent TB are provided the option of receiving INH therapy. (Because the therapy can have serious side effects, including liver damage, it is not mandatory.) All inmates with latent TB are monitored for the clinical symptoms suggestive of active TB, and periodically given chest x-rays. Inmates with latent TB are not, however, removed from the general prison population. By contrast, inmates with active TB are placed in “respiratory isolation”; that is, these inmates do not share a common breathing space with persons who do not have active TB.

This case is about what happened to inmates who declined to take the PPD test— the test for latent TB — during Greifinger’s tenure as Chief Medical Officer of DOCS. DOCS did not administer the PPD test without an inmate’s consent. Instead, inmates who declined to take the test were counseled about the test, and encouraged to consent to it. If they continued to refuse, they were placed in a status called “medical keeplock.” Inmates in medical keeplock were not permitted to leave their cells, except for a ten-minute shower once a week. Also, they were not permitted to receive visitors, except their attorneys. These conditions, particularly the bar on out-of-cell exercise, were more stringent than those imposed on prisoners in solitary confinement, who were permitted an hour of exercise daily.

Somewhat surprisingly (given its name), medical keeplock apparently involved few safeguards against contagion. Inmates in medical keeplock were counseled regularly about the benefits of consenting to the PPD test. However, prison personnel who interacted with the inmates did not wear masks, and the air the inmates breathed was not filtered or sectioned off in any way from that circulating in other parts of the prison. Moreover, the inmates did not wear masks during their showers or when they met with their attorneys — meetings which, at least in the facility at issue in this case, occurred in the prison’s visiting room, an area presumably frequented by members of the public. See Jolly v. Coughlin, 894 F.Supp. 734, 738 (S.D.N.Y.1995) (describing keeplock policy at Sing Sing Correctional Facility), aff'd, 76 F.3d 468 (2d Cir.1996).

The plaintiff in this case, Bobby Williams, is imprisoned at Sing Sing Correctional Facility. According to his complaint, on March 2, 1993, he refused a PPD test; the refusal was based on his claim that after a PPD test in December 1991 he had experienced a “very mysterious breathing problem.” Joint App. at 8. As a result of the 1993 refusal, Williams was placed in medical keeplock, where he remained for 589 days, receiving regular counseling about the virtues of PPD testing, but no exercise outside his cell. 2 On October 12, 1994, Williams gave up and ac *702 cepted a PPD test. He was then returned to the general prison population.

After exhausting prison grievance procedures, Williams filed a pro se complaint in the district court in January of 1995, seeking damages for the “inhumane condition of confinement” he had experienced. Joint App. at 9. Williams named as a defendant Robert Greifinger, Deputy Commissioner and Chief Medical Officer of the New York State Department of Correctional Services. Greifinger was then DOCS’s chief medical official and was responsible for developing the medical keeplock policy. In March of 1995, Williams moved for summary judgment, seeking a finding that his constitutional rights had been violated as a matter of law. Greifinger cross-moved for summary judgment, asserting (1) that he should prevail under the Eighth Amendment, and (2) that he was immune from suit under the doctrine of qualified immunity. Although the parties supplied the district court with a number of affidavits, no discovery preceded the motions.

The district court found that Williams was entitled to summary judgment on the Eighth Amendment claim, stating that “[t]he cases ...

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Clark v. Valletta
Second Circuit, 2025
Brown v. Reis
D. Connecticut, 2024
Coarts v. Quiros
D. Connecticut, 2024
Jordan v. Dept. of Correction
D. Connecticut, 2024
Booker v. Griffin
S.D. New York, 2024
Robinson v. Rodriguez
D. Connecticut, 2023
Rogers v. Lamont
D. Connecticut, 2023
Thompson v. City of New York
S.D. New York, 2023
Green v. Caron
D. Connecticut, 2023
BRANDT v. CIRILLO
D. New Jersey, 2023
Michael Johnson v. Susan Prentice
47 F.4th 529 (Seventh Circuit, 2022)
Milner v. Lamont
D. Connecticut, 2022
Baltas v. Jones
D. Connecticut, 2021
Jusino v. Quiros
D. Connecticut, 2021
Davies v. Hickley
D. Connecticut, 2021
Conley v. Aldi
D. Connecticut, 2021

Cite This Page — Counsel Stack

Bluebook (online)
97 F.3d 699, 1996 U.S. App. LEXIS 26793, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bobby-williams-v-robert-b-greifinger-deputy-commissioner-and-chief-ca2-1996.